5-BPDi (Indanyl-α-PHP) is a substituted cathinone derivative with stimulant effects which has been sold as a designer drug, first reported in 2015.[1][2]

5-BPDi
Legal status
Legal status
Identifiers
  • 1-(2,3-dihydro-1H-inden-5-yl)-2-pyrrolidin-1-ylhexan-1-one
CAS Number
PubChem CID
UNII
Chemical and physical data
FormulaC19H27NO
Molar mass285.431 g·mol−1
3D model (JSmol)
  • CCCCC(C(=O)C1=CC2=C(CCC2)C=C1)N3CCCC3
  • InChI=1S/C19H27NO/c1-2-3-9-18(20-12-4-5-13-20)19(21)17-11-10-15-7-6-8-16(15)14-17/h10-11,14,18H,2-9,12-13H2,1H3
  • Key:WETQQOQCDBNIKE-UHFFFAOYSA-N

See also

edit

References

edit
  1. ^ Błażewicz A, Bednarek E, Popławska M, Olech N, Sitkowski J, Kozerski L (July 2019). "Identification and structural characterization of synthetic cathinones: N-propylcathinone, 2,4-dimethylmethcathinone, 2,4-dimethylethcathinone, 2,4-dimethyl-α-pyrrolidinopropiophenone, 4-bromo-α-pyrrolidinopropiophenone, 1-(2,3-dihydro-1H-inden-5-yl)-2-(pyrrolidin-1-yl)hexan-1-one and 2,4-dimethylisocathinone". Forensic Toxicology. 37 (2): 288–307. doi:10.1007/s11419-018-00463-w.
  2. ^ Pulver B, Riedel J, Westphal F, Luhn S, Schönberger T, Schäper J, et al. (January 2023). "A new synthetic cathinone: 3,4-EtPV or 3,4-Pr-PipVP? An unsuccessful attempt to circumvent the German legislation on new psychoactive substances". Drug Testing and Analysis. 15 (1): 84–96. doi:10.1002/dta.3371. PMID 36136085.